Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul E Pfeffer

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Plos One|August 30, 2018
Effects of vitamin D on inflammatory and oxidative stress responses of human bronchial epithelial cells exposed to particulate matterPaul E Pfeffer, Haw Lu, Elizabeth H Mann, et al.
Thorax|December 10, 2020
Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic eraDavid J Jackson, John Busby, Paul E Pfeffer, et al.
ERJ Open Research|January 21, 2026
Real-world effectiveness of biologic therapies in severe asthma patients ineligible for phase 3 randomised controlled trials of biologics: an analysis from the UK Severe Asthma RegistryPaul E Pfeffer, Jola Karaj, Thomas Brown, et al.
The Journal of Allergy and Clinical Immunology. Global|July 29, 2024
Impact of comorbidities on EQ-5D quality-of-life index in severe asthmaPaul E Pfeffer, Thomas Brown, Rekha Chaudhuri, et al.
Thorax|November 24, 2022
Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK)Florence Tydeman, Paul E Pfeffer, Giulia Vivaldi, et al.
Clinical Medicine (London, England)|June 9, 2021
Post-COVID symptoms reported at asynchronous virtual review and stratified follow-up after COVID-19 pneumoniaRebecca R Taylor, Bhavi Trivedi, Neena Patel, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 7, 2025
Observational Analysis of Biological Remission as a Treatment Target for Severe Asthma: UK Severe Asthma RegistryP Jane McDowell, Charlene Redmond, John Busby, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 18, 2021
Factors Associated with Frequent Exacerbations in the UK Severe Asthma RegistryFreda Yang, John Busby, Liam G Heaney, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 31, 2024
Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With BenralizumabDavid J Jackson, Hassan Burhan, Hitasha Rupani, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 9, 2021
Ethnic Differences in Severe Asthma Clinical Care and Outcomes: An Analysis of United Kingdom Primary and Specialist CareJohn Busby, Liam G Heaney, Thomas Brown, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Plos One|August 30, 2018
Effects of vitamin D on inflammatory and oxidative stress responses of human bronchial epithelial cells exposed to particulate matterPaul E Pfeffer, Haw Lu, Elizabeth H Mann, et al.
Thorax|December 10, 2020
Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic eraDavid J Jackson, John Busby, Paul E Pfeffer, et al.
ERJ Open Research|January 21, 2026
Real-world effectiveness of biologic therapies in severe asthma patients ineligible for phase 3 randomised controlled trials of biologics: an analysis from the UK Severe Asthma RegistryPaul E Pfeffer, Jola Karaj, Thomas Brown, et al.
The Journal of Allergy and Clinical Immunology. Global|July 29, 2024
Impact of comorbidities on EQ-5D quality-of-life index in severe asthmaPaul E Pfeffer, Thomas Brown, Rekha Chaudhuri, et al.
Thorax|November 24, 2022
Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK)Florence Tydeman, Paul E Pfeffer, Giulia Vivaldi, et al.
Clinical Medicine (London, England)|June 9, 2021
Post-COVID symptoms reported at asynchronous virtual review and stratified follow-up after COVID-19 pneumoniaRebecca R Taylor, Bhavi Trivedi, Neena Patel, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 7, 2025
Observational Analysis of Biological Remission as a Treatment Target for Severe Asthma: UK Severe Asthma RegistryP Jane McDowell, Charlene Redmond, John Busby, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 18, 2021
Factors Associated with Frequent Exacerbations in the UK Severe Asthma RegistryFreda Yang, John Busby, Liam G Heaney, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 31, 2024
Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With BenralizumabDavid J Jackson, Hassan Burhan, Hitasha Rupani, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 9, 2021
Ethnic Differences in Severe Asthma Clinical Care and Outcomes: An Analysis of United Kingdom Primary and Specialist CareJohn Busby, Liam G Heaney, Thomas Brown, et al.
Pageof 9